Inhibition of the IRE1ALPHA-XBP1 pathway using toyocamycin as a novel way to inhibit progression of autosomal dominant polycystic kidney and liver disease
Active Project Grant Awarded Last action
- Award ID
- W81XWH2210005
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,639,485
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 98% complete
- Originally
- Place of performance
- New Haven, CT 06511, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $2,639,485 |
Quick answers
Who received award W81XWH2210005?
W81XWH2210005 was awarded to Yale Univ by Defense Health Agency (Department of Defense) on December 1, 2021.
How much is award W81XWH2210005 worth?
$2,639,485 has been obligated on W81XWH2210005.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award